Latest Interviews
Showing 2956–2970 of 3,055 transcripts.
Clear all filters- Milken Institute1h 4m
Is Gender Parity Possible in the 21st Century?
Molly Ashby, Geena Davis, Deborah DeHaas, Manju Ganeriwala, Ann McElaney-Johnson, Willow Bay, Kathleen Sullivan, Subha Barry, Dr. Nita Arindapol, Kelly McElhaney, Brenda Bates, Nancy, Chris McGrath
A recent panel featuring Geena Davis and industry leaders from academia, finance, and government exposed severe gender disparities in family media, corporate leadership, and political representation, projecting that parity could take centuries at current rates. Speakers argued that these gaps stem from early media conditioning, retention failures, and cultural narratives that limit women's career aspirations, necessitating structural solutions like Norway-style quotas, diverse talent databases, and intentional content rewriting. The group concluded that achieving Hillary Clinton's 2050 vision of 50% global female leadership requires a mandatory shift from voluntary goodwill to accountability models driven by the economic necessity of talent scarcity and Millennial consumer pressure.
- Milken Institute1h 3m
Longevity Is Opportunity: Riding the Demographic Wave
Pinchas Cohen, Michael Hodin, Dan Houston, Paul Irving, Jody Holtzman, Eric Schmidt
Driven by a historic demographic inversion where the over-60 population now exceeds the under-14 group, the traditional retirement model has collapsed due to extended lifespans outpacing savings and healthcare innovations. This shift has catalyzed a $3.5 trillion market dominated by the over-50 demographic, prompting corporate leaders and investors to pivot from acute care toward prevention, wellness, and extended career engagement strategies. Organizations like BMW and emerging startups such as Neuropath are now adapting workplace structures and diagnostic technologies to address the financial, biological, and social challenges of an aging global workforce.
- Milken Institute1h 2m
How Improved Health and Longer Lives Drive Global Prosperity
Thomas Frieden, Jonathan Gluck, Carole Roan Gresenz, Michael Harsh, Peter Margolis, Ceci Connolly
A panel of experts from the CDC, GE Health Care, and leading academic institutions demonstrated that shifting from fee-for-service models to accountable care systems can simultaneously improve population health and reduce long-term costs through specific innovations like immunizations and diagnostic imaging. By leveraging data standardization, prize challenges, and telehealth pilots, the session highlighted how eliminating clinical variation and preventing disease rather than treating it generates billions in annual societal savings. The discussion concluded that political and payment reforms, rather than technological limitations, remain the primary obstacles to fully realizing these economic benefits and fostering entrepreneurial growth through universal insurance access.
- Milken Institute1h 0m
Teacher Evaluation and National Testing: Can We Reach Consensus?
Yvonne Chan, Jason Culbertson, Warren Fletcher, Patrice Pujol, Thomas Boysen, Tom Boyce
A multi-organization panel detailed a strategic shift from seniority-based compensation to data-driven teacher effectiveness models, citing the Gates Foundation's MET study and three case studies: Vaughan Learning Center, the United Teachers of Los Angeles, and Ascension Parish Schools. These initiatives replaced rigid testing mandates with comprehensive evaluation systems featuring calibrated peer observations, performance-linked pay, and targeted professional development to address high turnover and achievement gaps. Consensus among educators, union leaders, and administrators emphasizes that successful implementation requires rigorous evaluator training, realistic performance distributions, and a cultural transition from adversarial oversight to collaborative professional communities.
- Milken Institute1h 3m
Israel: The Ingenuity Society as Global Laboratory
Yosef Abramowitz, Mark Kahn, Andrew Neff, Amir Peleg, Eyal Rosner, Eugene Kandel, Steven Yeager, Amir Shachar, Yossi Levitini, Jason, Gerhard Hoffstaedter
Israeli industry leaders and government officials outlined a strategic framework positioning the nation as a global laboratory for testing solutions to scarcity-driven challenges in sectors ranging from renewable energy and agritech to water management. Key initiatives include Arava Power Company's expansion of solar infrastructure into Africa, the Alternative Fuel Initiative's push for a 60% reduction in transportation oil consumption by 2025, and Omnivore Partners' pivot toward addressing global commodity crop needs through international research stations. This ecosystem leverages military talent and public-private partnerships to overcome domestic market limitations, aiming to secure significant export markets while mitigating political risks through multilateral financial guarantees.
- Milken Institute1h 1m
Reform 3.0: China's Next Direction
Evan Feigenbaum, Robert Hormats, James McGregor, Perry Wong, Mei Fong, Bob Hormats, Jim McGregor
China's leadership is steering "Reform 3.0" to transition the economy from investment-led growth to a consumption-driven model, prioritizing quality and equity over rapid expansion despite structural bottlenecks. Facing a demographic crisis, environmental degradation, and entrenched vested interests, President Xi Jinping has consolidated power to implement experimental pilots in fiscal decentralization and household registration reform. While political liberalization is unlikely, the strategy focuses on converting migrant workers into legal citizens and opening capital markets to sustain long-term stability and international competitiveness.
- Milken Institute1h 12m
Lunch Panel: A Cure for What Ails Us: Celebrating the Impact of Science
Nancy Brown, Francis Collins, Thomas Frieden, Andrew von Eschenbach, Michael Milken
The bioscience forum highlighted the sector's massive contribution to increased global life expectancy and economic growth while emphasizing that flat budgets and inflation have critically reduced NIH grant success rates to below 20%. Distinguished leaders such as Francis Collins and Tom Frieden warned that sustained funding cuts and a 90% treatment-versus-prevention spending imbalance threaten American innovation and the careers of young researchers. Despite these financial constraints, the event underscored significant breakthroughs in areas like genomic medicine and disease eradication, with panelists urging renewed investment to maintain global health leadership and drive future discoveries.
- Milken Institute1h 12m
The Rise of Social Capital Markets: How Will They Change the World?
Alex Friedman, Ron Cordes, Rush Ramsey, Bobby Turner, Gene Case, Mark Rowan, Shari Berenbach, Eva
Social capital markets currently operate as an nascent asset class hindered by regulatory barriers, ambiguous definitions, and institutional resistance, despite a projected trillion-dollar opportunity that could bridge the growing gap between societal needs and declining government funding. Prominent figures like Bobby Turner and Ron Cordes are pioneering strategies to overcome these hurdles, exemplified by the Canyon Agassiz Fund's rapid fundraising success and the creation of public data infrastructure that connects high-net-worth demand with vetted impact managers. As generational values shift and technology enables retail participation through crowdfunding and securitization, the sector anticipates a "10-year overnight success" moment driven by blended finance models and potential regulatory mandates for social performance disclosure.
- Milken Institute1h 0m
Bioscience Discoveries That Will Blow Your Mind
Jack Andraka, David Baltimore, Francis Collins, Tejal Desai, Aydogan Ozcan, Margaret Anderson
A panel of leading scientists including Jack Andraka, Tejal Desai, David Baltimore, and Francis Collins outlined breakthrough innovations in cancer detection, gene therapy, and nanotechnology while highlighting the transformative potential of open-access data. Despite rapid advancements in genomic sequencing and portable diagnostics, experts warned of a critical decline in U.S. biomedical funding that is discouraging young researchers from pursuing high-risk scientific careers. The discussion concluded with calls to establish special grant programs for early-career innovators and to restore emphasis on curiosity-driven education to sustain future scientific progress.
- Milken Institute1h 12m
Reading the Tea Leaves: Where Are Markets Headed?
John Calamos Sr., Anne Casscells, George Evans, J. Todd Morley, John Rogers Jr., Christopher Ailman, Chris Ailman
Moderated by CalSTRS CIO Chris Ailman, a panel of five prominent investment leaders debated whether the U.S. economy has settled into a "new normal" of slower growth or is returning to an "old normal" of higher expansion. While Ann Cassells and John Rogers offered divergent GDP forecasts based on demographic shifts and housing recovery, other panelists like Todd Morley and John Calamost warned of imminent violent reflation and market distortions caused by excessive monetary stimulus. Ultimately, the consensus urged investors to abandon traditional 401(k) allocations in favor of hard assets, private credit, and global consumer brands to navigate an era defined by structural market dysfunction and potential currency devaluation.
- Milken Institute1h 3m
Impatient Patients: How Disease Organizations Are Accelerating Research
Margaret Anderson, Lou DiGennaro, Jonathan Simons, Gordon Gunn, Deborah Black, John Walsh
Representatives from Faster Cures and five major disease-focused nonprofits outlined how venture philanthropy and patient-led activism accelerate cures by de-risking early-stage research and navigating the "Valley of Death" between discovery and clinical application. Leaders from the Leukemia and Lymphoma Society, Prostate Cancer Foundation, and the Alpha-1 Foundation detailed strategic investments that generated massive financial leverage and established critical infrastructure, such as patient registries and rapid autopsy programs, to overcome funding gaps and accelerate trial recruitment. The panel concluded that sustainable progress requires aligning academia, industry, and regulators while empowering patients to actively define research priorities and drive policy changes for faster approvals and reimbursement.
- Milken Institute1h 3m
How Social Responsibility Inspires Employees and Serves Investors
Jared Carney, Kelly McElhaney, Christine McGrath, Alatha Reddy, Joe Torrey, Aileen Yang, Michael Royce, J.J. Allen, Delilah Rothenberg
A panel of executives from Prudential, Mondelez International, MLB, and Walmart defines modern corporate social responsibility as a core business strategy rather than ancillary philanthropy, emphasizing alignment between CSR initiatives and commercial objectives. Leaders from these organizations illustrate this shift through specific operational models, including Mondelez's $600 million supply chain investment, Prudential's impact investing for UNICEF, and MLB's revenue-funded community programs designed to secure long-term fan bases. The discussion further highlights how investor pressure, millennial talent recruitment, and the need for hyper-transparency have elevated CSR to a critical governance function where the Board and C-Suite actively oversee risk management and strategic outcomes.
- Milken Institute54 min
Evolving Opportunities in Capital Markets
Mark Antonacio, Colleen Campbell, Lowell Craft, Soren Reinertsen, Justin Slacky
Mark Antonacio, Colleen Campbell, and four other financial experts convened to analyze credit market risks characterized by a potential leveraged loan bubble, deteriorating covenant quality, and an artificially extended cycle driven by Federal Reserve stimulus. The panelists highlighted a structural divergence where record refinancing volumes mask stable leverage metrics, while regulatory shifts force banks out of middle-market lending and onto non-traditional sectors like energy and infrastructure. Ultimately, the discussion identified liquidity constraints and pension fund underfunding as primary near-term threats, prompting a strategic shift toward consolidation in alternative asset management and increased reliance on private credit vehicles.
- Milken Institute1h 2m
The Business of Sports
Jim Gray, Todd Boley, Melinda Whitmer, Wayne Gretzky, Jimmy Connors, Joe Ravitch
Industry leaders including Guggenheim Partners' Todd Boley and Hall of Famer Wayne Gretzky convened to analyze the shifting economics of professional sports, where franchise valuations are increasingly driven by real estate and the strategic removal of Regional Sports Network middlemen. The panel highlighted a critical transition toward direct-to-consumer broadcasting models, exemplified by Time Warner Cable's $10 billion investment in Dodgers and Lakers rights, while maintaining that the unique energy of live stadium attendance remains irreplaceable by digital technology. Despite concerns over potential tech giant disruption, the consensus asserts that sports franchises will continue to leverage their status as non-substitutable entertainment anchors to sustain growth and justify rising consumer costs.
- Milken Institute1h 11m
India: How Long a Pause?
Sam Gupta, Nandita Agarwal Parker, Sanjay Patel, Rashesh Shah, Man Jit Singh, Komal Sri-Kumar, Nandita Parker, Sanjay Gupta, Dilip Thakur, John Shulha, Rabindranath Dutta, Vivek Wadhwa, Manju Ganeriwala, Nati Krishna, Vimal
The Indian economy is navigating a temporary 12-to-18-month pause characterized by political gridlock and high corporate leverage, yet retains significant value due to undervalued market cap-to-GDP ratios and robust foreign investment inflows. Amidst a demographic dividend where 75% of the population is under 35, a shifting middle class is driving premium consumer demand and digital adoption, particularly in media and private equity sectors. While infrastructure bottlenecks and governance risks constrain long-term growth potential, analysts project a return to 8–10% GDP expansion as capital expenditure resumes and regional markets mature beyond the current English-dominated internet landscape.